Tech Company Financing Transactions
Xortx Therapeutics Funding Round
Xortx Therapeutics, based in Calgary, Alberta, secured $2.5 million from private investors.
Transaction Overview
Company Name
Announced On
2/15/2024
Transaction Type
Venture Equity
Amount
$2,500,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
33rd Street NW 3710
Calgary, Alberta, T2L 2M1
Canada
Calgary, Alberta, T2L 2M1
Canada
Phone
Website
Email Address
Overview
XORTX Therapeutics, Inc. is a drug based biotechnology company primarily focused on orphan disease indications which have aberrant purine metabolism and frequently high serum uric acid imbalance. Our focus on developing kidney therapies also includes therapeutics programs for large markets such as diabetic nephropathy and acute kidney injury associated with respiratory virus infections such as SARS-CoV-2.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Allen Davidoff
Chief Financial Officer
James Fairbairn
Chief Medical Officer
Stephen Haworth
Chief Technical Officer
David MacDonald
VP - Bus. Development
Stacy Evans
Browse more venture capital transactions:
Prev: 2/15/2024: Duetti venture capital transaction
Next: 2/15/2024: Monumental venture capital transaction
Share this article
News on VC Transactions
We do our best to document all VC transactions involving tech companies. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs